期刊文献+

华法林使用中的几个问题 被引量:2

下载PDF
导出
摘要 1问题:影响华法林抗凝效果的因素有哪些? 回答:由于房颤患者发生缺血性脑卒中危险性是无房颤者的5倍,其病死率增加2倍,故在房颤治疗中抗凝治疗防止血栓栓塞事件发生十分重要。研究表明华法林抗凝治疗可使脑卒中的发生率减少2/3,病死率下降1/3,而用阿司匹林预防血栓栓塞发生疗效仅为华法林的1/2。
作者 那开宪
出处 《中国医刊》 CAS 2011年第9期89-90,共2页 Chinese Journal of Medicine
  • 相关文献

同被引文献15

  • 1Murphy N F,Simpson C R,Jhund P S,et al.A national survey of the prevalence,incidence,primary care burden and treatment of atrial fibrillation in Scotland[J].Heart,2007,93(5):606-612.
  • 2Fuster V,Rydén L E,Cannom D S,et al.ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Revise the 2001guidelines for the management of patients with atrial fibrillation)developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society[J].Europace,2006,8(9):651-745.
  • 3Frost L,Engholm G,Johnsen S,et al.Incident stroke after discharge from the hosp ital with a diagnosis of atrial fibrillation[J].Am J Med,2000,108(1):36-40.
  • 4Pisters R,Lane D A,Nieuwlaat R,et al.A novel userfriendly score(HAS-BLED)to assess 1-year risk of major bleeding in patients with atrial fibrillation:the Euro Heart Survey[J].Chest,2010,138(5):1093-1100.
  • 5Camm A J,Lip G Y,De Caterina R,et al.2012focused update of the ESC Guidelines for the management of atrial fibrillation:an update of the 2010 ESC Guidelines for the mana gement of atrial fibrillation developed with the special contribution of the European HeartRhythm Association[J].Europace,2012,14(10):1385-1413.
  • 6ACTIVE Investigatiors,Connolly S J,Pogue J,et al.Effect of clopidogrel added to aspirin in patients with atrial fibrillation[J].N Engl J Med,2009,360(20):2066-2078.
  • 7Sato H,Ishikawa K,Kitabatake A,et al.Lowdose aspirin for prevention of stroke in low-risk patients with atrial fibrillation:Japan Atrial Fibrillation Stroke Trial[J].Stroke,2006,37(2):447-451.
  • 8Olesen J B,Lip G Y,Lindhardsen J,et al.Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation:A net clinical benefit analysis using a'real world'nationwide cohort study[J].Thromb Haemost,2011,106(4):739-749.
  • 9JCS Joint Working Group.Guidelines for pharmacotherapy of atrial fibrillation(JCS2008):digest version[J].Circ J,2010,74(11):2479-2500.
  • 10Liu B,Liu L Z,Xuan J,et al.Treatment patterns associated with storke prevention in patients with atrial fibrillation in three major cities in the People's Republic of China[J].Int J Gen Med,2013,7:29-35.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部